Transformation of Acute Cancer Pain to Chronic Cancer Pain Syndromes

Journal of Supportive Oncology

Volumn 10, Issue 3, 2012, Pages 89-95

  Burton, Allen W ^a   Fine, Perry G ^b   Passik, Steven D ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; FENTANYL; FENTANYL CITRATE; GABAPENTIN; NARCOTIC ANALGESIC AGENT; PLATINUM COMPLEX; TAXANE DERIVATIVE;

ACUPUNCTURE; ANALGESIC AGENT ABUSE; APPLICATION SITE IRRITATION; BREAKTHROUGH PAIN; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER SURVIVOR; CHRONIC PAIN; HEAD AND NECK CANCER; HUMAN; JAW OSTEONECROSIS; MASTALGIA; MOUTH DISEASE; NEUROPATHIC PAIN; NEUROPATHY; OPIATE ADDICTION; PAIN ASSESSMENT; PHANTOM PAIN; POSTOPERATIVE PAIN; PREVALENCE; PSYCHOLOGICAL WELL BEING; REVIEW; RISK ASSESSMENT;

ACUTE DISEASE; ANALGESICS; BREAKTHROUGH PAIN; CHRONIC PAIN; COMPLEMENTARY THERAPIES; DISEASE PROGRESSION; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT; PREVALENCE; RISK ASSESSMENT; SURVIVORS;

EID: 84860632400     PISSN: 15446794     EISSN: 1879596X     Source Type: Journal    
DOI: 10.1016/j.suponc.2011.08.004     Document Type: Review

References (80)

1. Altekruse S.F., Kosary C.L., Krapcho M., et al. SEER Cancer Statistics Review 1975-2007, National Cancer Institute, Bethesda, MD.
2. Pioneering Survivorship: Twenty Years of Advocating for Quality Cancer Care. 2005 annual report 2006, National Coalition for Cancer Survivorship, NCCS, Silver Spring, MD. http://www.canceradvocacy.org/assets/documents/2005-annual-report.pdf.
3. Shaiova L., Lapin J., Manco L.S., et al. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Support Care Cancer 2004, 12:268-273.
4. Ganz P.A. Late effects of cancer and its treatment. Semin Oncol Nurs 2001, 17:241-248.
5. Mariotto A.B., Rowland J.H., Yabroff K.R., et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 2009, 18:1033-1040.
6. Geenen M.M., Cardous-Ubbink M.C., Kremer L.C., et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007, 297:2705-2715.
7. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007, 18:1437-1449.
8. Carr D.B., Goudas L.C. Acute pain. Lancet 1999, 353:2051-2058.
9. Green C.R., Montague L., Hart-Johnson T.A. Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination. J Pain Symptom Manage 2009, 37(5):831-847.
10. Montague L., Green C.R. Cancer and breakthrough pain's impact on a diverse population. Pain Med 2009, 10(3):549-561.
11. McCarberg B.H., Nicholson B.D., Todd K.H., et al. The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey. Am J Ther 2008, 15:312-320.
12. Vartanian J.G., Carvalho A.L., Toyota J., et al. Socioeconomic effects of and risk factors for disability in long-term survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg 2006, 132:32-35.
13. Levy M.H., Chwistek M., Mehta R.S. Management of chronic pain in cancer survivors. Cancer J 2008, 14:401-409.
14. Loeser J.D., Treede R.D. The Kyoto protocol of IASP basic pain terminology. Pain 2008, 137:473-477.
15. Caraceni A., Martini C., Zecca E., et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 2004, 18:177-183.
16. Fine P. Breakthrough pain. Cancer Pain: Assessment and Management 2003, 408-411. Cambridge University Press, Cambridge, UK. E. Bruera, R.K. Portenoy (Eds.).
17. Hwang S.S., Chang V.T., Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 2003, 101:55-64.
18. Payne R. Recognition and diagnosis of breakthrough pain. Pain Med 2007, 8(suppl 1):S3-S7.
19. Portenoy R.K., Payne D., Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999, 81:129-134.
20. Fishbain D.A. Pharmacotherapeutic management of breakthrough pain in patients with chronic persistent pain. Am J Manag Care 2008, 14:S123-S128.
21. Portenoy R.K., Hagen N.A. Breakthrough pain: definition, prevalence and characteristics. Pain 1990, 41:273-281.
22. Shoemaker S, Bruns D, Portenoy RK. Characteristics and impact of breakthrough pain (BTP) in noncancer and cancer-related chronic pain managed by clinicians who are not pain specialists. Presented at the American Academy of Pain Medicine 25th Annual Meeting, Honolulu, HI, January 28-31, 2009.
23. Svendsen K.B., Andersen S., Arnason S., et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 2005, 9:195-206.
24. Davis M.P., Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care 2004, 21:137-142.
25. Windebank A.J., Grisold W. Chemotherapy-induced neuropathy. J Periph Nerv Syst 2008, 13:27-46.
26. Gartner R., Jensen M.B., Nielsen J., et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009, 302:1985-1992.
27. Parker R.G., Berry H.C. Late effects of therapeutic irradiation on the skeleton and bone marrow. Cancer 1976, 37:1162-1171.
28. Ogino I., Okamoto N., Ono Y., et al. Pelvic insufficiency fractures in postmenopausal woman with advanced cervical cancer treated by radiotherapy. Radiother Oncol 2003, 68:61-67.
29. Burton A.W., Fanciullo G.J., Beasley R.D., et al. Chronic pain in the cancer survivor: a new frontier. Pain Med 2007, 8:189-198.
30. Clinical practice guidelines in oncology. Adult cancer pain 2009 National Comprehensive Cancer Network (NCCN), Accessed October 8, 2011. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
31. Greenwald H.P. Interethnic differences in pain perception. Pain 1991, 44:157-163.
32. Rudy T.E., Kerns R.D., Turk D.C. Chronic pain and depression: toward a cognitive-behavioral mediation model. Pain 1988, 35:129-140.
33. Caraceni A., Brunelli C., Martini C., et al. Cancer pain assessment in clinical trials. A review of the literature (1999-2002). J Pain Symptom Manage 2005, 129:507-519.
34. De Conno F., Caraceni A., Gamba A., et al. Pain measurement in cancer patients: a comparison of six methods. Pain 1994, 57:161-166.
35. Hakonsen G.D., Hudson S., Loennechen T. Design and validation of a medication assessment tool for cancer pain management. Pharm World Sci 2006, 28:342-351.
36. Wong D.L., Baker C.M. Pain in children: comparison of assessment scales. Pediatr Nurs 1988, 14:9-17.
37. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975, 1:277-299.
38. Cleeland C.S., Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994, 23:129-138.
39. Furstenberg C.T., Ahles T.A., Whedon M.B., et al. Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manage 1998, 15:335-349.
40. Holen J.C., Hjermstad M.J., Loge J.H., et al. Pain assessment tools: is the content appropriate for use in palliative care?. J Pain Symptom Manage 2006, 32:567-580.
41. Sloan P.A., Donnelly M.B., Vanderveer B., et al. Cancer pain education among family physicians. J Pain Symptom Manage 1997, 14:74-81.
42. Sloan P.A., Vanderveer B.L., Snapp J.S., et al. Cancer pain assessment and management recommendations by hospice nurses. University of Kentucky, Lexington, Kentucky. J Pain Symptom Manage 1999, 18:103-110.
43. Cancer Pain Relief 1996, World Health Organization, Geneva. 2nd ed.
44. Burton A.W., Hamid B. Current challenges in cancer pain management: does the WHO ladder approach still have relevance?. Expert Rev Anticancer Ther 2007, 7:1501-1502.
45. Fine P.G., Miaskowski C., Paice J.A. Meeting the challenges in cancer pain management. J Support Oncol 2004, 2:5-24.
46. Ahmedzai S.H., Boland J. The total challenge of cancer pain in supportive and palliative care. Curr Opin Support Palliat Care 2007, 1:3-5.
47. Reder R.F. Opioid formulations: tailoring to the needs in chronic pain. Eur J Pain 2001, 5(suppl A):109-111.
48. Reimer K., Hopp M., Zenz M., et al. Meeting the challenges of opioid-induced constipation in chronic pain management-a novel approach. Pharmacology 2009, 83:10-17.
49. Flor H., Fydrich T., Turk D.C. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 1992, 49:221-230.
50. Levy M.H., Samuel T.A. Management of cancer pain. Semin Oncol 2005, 32:179-193.
51. McGeeney B.E. Adjuvant agents in cancer pain. Clin J Pain 2008, 24(suppl 10):S14-S20.
52. Mercadante S., Portenoy R.K. Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage 2001, 21:338-354.
53. Caraceni A., Zecca E., Bonezzi C., et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004, 22:2909-2917.
54. Hugel H., Ellershaw J.E., Dickman A. Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain. J Pain Symptom Manage 2003, 26:1073-1074.
55. Fitzgibbon D. Interventional procedures for cancer pain management: selecting the right procedure at the right time. J Support Oncol 2010, 8:60-61.
56. Breitbart W., Passik S.D., Rosenfeld B. Cancer pain and AIDS-related pain: psychiatric and ethical issues. Handbook of Pain Management 2003, 689-720. Churchill Livingstone, New York. R. Melzack, P. Wall (Eds.).
57. Acupuncture: National Institutes of Health Consensus Development Conference statement. Dermatol Nurs 2000, 12:126-133. National Institutes of Health.
58. Andersen B.L. Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol 1992, 60:552-568.
59. Cassileth B.R., Vickers A.J. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 2004, 28:244-249.
60. Kabat-Zinn J., Lipworth L., Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med 1985, 8:163-190.
61. Sellick S.M., Zaza C. Critical review of 5 nonpharmacologic strategies for managing cancer pain. Cancer Prev Control 1998, 2:7-14.
62. Ernst E., Pittler M.H. The effectiveness of acupuncture in treating acute dental pain: a systematic review. Br Dent J 1998, 184:443-447.
63. Green S., Buchbinder R., Hetrick S. Acupuncture for shoulder pain. Cochrane Database Syst Rev 2005, CD005319.
64. Manheimer E., Linde K., Lao L., et al. Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med 2007, 146:868-877.
65. Trinh K., Graham N., Gross A., et al. Acupuncture for neck disorders. Spine 2007, 32:236-243.
66. Alimi D., Rubino C., Pichard-Leandri E., et al. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003, 21:4120-4126.
67. Cephalon Inc. Actiq (oral transmucosal fentanyl citrate lozenge). Prescribing information. Revised 2007.
68. Cephalon Inc. Fentora (fentanyl buccal tablet). Prescribing information. Revised 2007.
69. Onsolis (fentanyl buccal soluble film). Prescribing information 2009, Meda Inc.
70. Nalamachu S., Hassman D., Wallace M.S., et al. Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain. Curr Med Res Opin 2011, 27(3):519-530.
71. Webster L.R., Fine P.G. Approaches to improve pain relief while minimizing opioid abuse liability. J Pain 2010, 11:602-611.
72. Webster L.R., Webster R.M. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005, 6:432-442.
73. Butler S.F., Budman S.H., Fernandez K.C., et al. Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R). J Addict Med 2009, 3:66-73.
74. Butler S.F., Fernandez K., Benoit C., et al. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain 2008, 9:360-372.
75. Compton P., Darakjian J., Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 1998, 16:355-363.
76. Passik S.D., Kirsh K.L., Whitcomb L., et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004, 26:552-561.
77. Adams L.L., Gatchel R.J., Robinson R.C., et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage 2004, 27:440-459.
78. Butler S.F., Budman S.H., Fernandez K.C., et al. Development and validation of the Current Opioid Misuse Measure. Pain 2007, 130:144-156.
79. Ives T.J., Chelminski P.R., Hammett-Stabler C.A., et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006, 6:46.
80. Gourlay D.L., Heit H.A. Risk management is everyone's business. Pain Med 2007, 8:125-127.